Zephyr Etude Post-Inscription (French Registry)

Active, not recruitingOBSERVATIONAL
Enrollment

155

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

June 22, 2022

Study Completion Date

September 30, 2025

Conditions
Emphysema or COPD
Interventions
DEVICE

Zephyr Valve

Subjects prescribed Zephyr Valve treatment for their emphysema/COPD and treated with the Zephyr Valves.

Trial Locations (12)

Unknown

Hôpital La Cavale Blanche, Brest

Hôpital François Mitterrand, Dijon

Hôpital Nord, Latronche

Hôpital Calmette, Lille

Hôpital Dupuytren, Limoges

Hôpital Arnaud de Villeneuve, Montpellier

Hôpital Bichat, Paris

Hôpital Cochin, Paris

Hôpital Charles Nicolle, Rouen

Hôpital Nord, Saint-Etienne

Nouvel Hôpital Civil, Strasbourg

Hôpital Larrey, Toulouse

All Listed Sponsors
lead

Pulmonx Corporation

INDUSTRY